Echo Pharmaceuticals B.V. - Product Pipeline Review - 2015

Published: Oct, 2015 | Pages: 23 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Echo Pharmaceuticals B.V. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Echo Pharmaceuticals B.V. - Product Pipeline Review - 2015', provides an overview of the Echo Pharmaceuticals B.V.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Echo Pharmaceuticals B.V.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Echo Pharmaceuticals B.V. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Echo Pharmaceuticals B.V.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Echo Pharmaceuticals B.V.'s pipeline products

Reasons to Buy

- Evaluate Echo Pharmaceuticals B.V.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Echo Pharmaceuticals B.V. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Echo Pharmaceuticals B.V.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Echo Pharmaceuticals B.V. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Echo Pharmaceuticals B.V.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Echo Pharmaceuticals B.V. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents

Table of Contents
 2
List of Tables 3
List of Figures 3
Echo Pharmaceuticals B.V. Snapshot 4
Echo Pharmaceuticals B.V. Overview 4
Key Information 4
Key Facts 4
Echo Pharmaceuticals B.V. - Research and Development Overview 5
Key Therapeutic Areas 5
Echo Pharmaceuticals B.V. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Echo Pharmaceuticals B.V. - Pipeline Products Glance 9
Echo Pharmaceuticals B.V. - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
Echo Pharmaceuticals B.V. - Early Stage Pipeline Products 11
Discovery Products/Combination Treatment Modalities 11
Echo Pharmaceuticals B.V. - Drug Profiles 12
dronabinol 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
ECP-012A 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
ECP-015 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Echo Pharmaceuticals B.V. - Pipeline Analysis 16
Echo Pharmaceuticals B.V. - Pipeline Products by Target 16
Echo Pharmaceuticals B.V. - Pipeline Products by Route of Administration 17
Echo Pharmaceuticals B.V. - Pipeline Products by Molecule Type 18
Echo Pharmaceuticals B.V. - Pipeline Products by Mechanism of Action 19
Echo Pharmaceuticals B.V. - Recent Pipeline Updates 20
Echo Pharmaceuticals B.V. - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 22
Disclaimer 23

List of Tables

Echo Pharmaceuticals B.V., Key Information 4
Echo Pharmaceuticals B.V., Key Facts 4
Echo Pharmaceuticals B.V. - Pipeline by Indication, 2015 6
Echo Pharmaceuticals B.V. - Pipeline by Stage of Development, 2015 7
Echo Pharmaceuticals B.V. - Monotherapy Products in Pipeline, 2015 8
Echo Pharmaceuticals B.V. - Phase II, 2015 9
Echo Pharmaceuticals B.V. - Phase I, 2015 10
Echo Pharmaceuticals B.V. - Discovery, 2015 11
Echo Pharmaceuticals B.V. - Pipeline by Target, 2015 16
Echo Pharmaceuticals B.V. - Pipeline by Route of Administration, 2015 17
Echo Pharmaceuticals B.V. - Pipeline by Molecule Type, 2015 18
Echo Pharmaceuticals B.V. - Pipeline Products by Mechanism of Action, 2015 19
Echo Pharmaceuticals B.V. - Recent Pipeline Updates, 2015 20
Echo Pharmaceuticals B.V., Other Locations 21